Rank | Gene Set | Z-score |
---|---|---|
1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 8.45613085 |
2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 8.00800981 |
3 | ATP synthesis coupled proton transport (GO:0015986) | 8.00800981 |
4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 7.81401534 |
5 | respiratory electron transport chain (GO:0022904) | 7.16587223 |
6 | electron transport chain (GO:0022900) | 7.00294173 |
7 | ribosomal small subunit assembly (GO:0000028) | 6.49251631 |
8 | translational elongation (GO:0006414) | 5.58967429 |
9 | protein neddylation (GO:0045116) | 5.12438363 |
10 | viral life cycle (GO:0019058) | 4.99010493 |
11 | chaperone-mediated protein transport (GO:0072321) | 4.96088660 |
12 | protein complex biogenesis (GO:0070271) | 4.85665817 |
13 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.80888655 |
14 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.80888655 |
15 | NADH dehydrogenase complex assembly (GO:0010257) | 4.80888655 |
16 | cellular protein complex disassembly (GO:0043624) | 4.78082963 |
17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.66043573 |
18 | oxidative phosphorylation (GO:0006119) | 4.64271688 |
19 | ATP biosynthetic process (GO:0006754) | 4.60132043 |
20 | translational initiation (GO:0006413) | 4.58968088 |
21 | hydrogen ion transmembrane transport (GO:1902600) | 4.49996092 |
22 | translation (GO:0006412) | 4.40941972 |
23 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.38635731 |
24 | fatty acid elongation (GO:0030497) | 4.33577384 |
25 | ribosomal large subunit biogenesis (GO:0042273) | 4.28209229 |
26 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.23635841 |
27 | central nervous system myelination (GO:0022010) | 4.21916423 |
28 | axon ensheathment in central nervous system (GO:0032291) | 4.21916423 |
29 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.18428419 |
30 | proton transport (GO:0015992) | 4.05687359 |
31 | maturation of SSU-rRNA (GO:0030490) | 4.04264865 |
32 | hydrogen transport (GO:0006818) | 3.99925696 |
33 | protein targeting to membrane (GO:0006612) | 3.94701455 |
34 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.92241310 |
35 | protein complex disassembly (GO:0043241) | 3.91007429 |
36 | inner mitochondrial membrane organization (GO:0007007) | 3.79713215 |
37 | macromolecular complex disassembly (GO:0032984) | 3.72165182 |
38 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.65001689 |
39 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.64864672 |
40 | respiratory chain complex IV assembly (GO:0008535) | 3.59674889 |
41 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.51478935 |
42 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.51008508 |
43 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.39478677 |
44 | cellular component biogenesis (GO:0044085) | 3.36318824 |
45 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.32457294 |
46 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.31903495 |
47 | negative regulation of ligase activity (GO:0051352) | 3.31903495 |
48 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.31117552 |
49 | DNA deamination (GO:0045006) | 3.25817305 |
50 | rRNA modification (GO:0000154) | 3.25273379 |
51 | deoxyribonucleotide catabolic process (GO:0009264) | 3.24901001 |
52 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.21953974 |
53 | iron-sulfur cluster assembly (GO:0016226) | 3.20343208 |
54 | metallo-sulfur cluster assembly (GO:0031163) | 3.20343208 |
55 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.19993118 |
56 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.19993118 |
57 | deoxyribose phosphate catabolic process (GO:0046386) | 3.18402934 |
58 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.17049187 |
59 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.17049187 |
60 | regulation of oxidative phosphorylation (GO:0002082) | 3.16858433 |
61 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.16090233 |
62 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.16090233 |
63 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.16090233 |
64 | mRNA catabolic process (GO:0006402) | 3.14180680 |
65 | base-excision repair, AP site formation (GO:0006285) | 3.12614076 |
66 | purine nucleotide salvage (GO:0032261) | 3.10405830 |
67 | cytochrome complex assembly (GO:0017004) | 3.10366430 |
68 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.09364187 |
69 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.09364187 |
70 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.09349166 |
71 | ribosomal small subunit biogenesis (GO:0042274) | 3.06729895 |
72 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.06632069 |
73 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.06533303 |
74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.06033144 |
75 | substantia nigra development (GO:0021762) | 3.05142886 |
76 | peptidyl-histidine modification (GO:0018202) | 3.04147525 |
77 | formation of translation preinitiation complex (GO:0001731) | 3.04093961 |
78 | mitochondrial transport (GO:0006839) | 3.03811336 |
79 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.02798235 |
80 | aerobic respiration (GO:0009060) | 3.02768472 |
81 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.02151262 |
82 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.02151262 |
83 | cullin deneddylation (GO:0010388) | 3.01284276 |
84 | pseudouridine synthesis (GO:0001522) | 3.00244597 |
85 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.98870814 |
86 | aldehyde catabolic process (GO:0046185) | 2.98730120 |
87 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.97500683 |
88 | protein targeting to mitochondrion (GO:0006626) | 2.97093772 |
89 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.96204960 |
90 | GTP biosynthetic process (GO:0006183) | 2.95899133 |
91 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.94063682 |
92 | cellular response to oxygen radical (GO:0071450) | 2.93440096 |
93 | removal of superoxide radicals (GO:0019430) | 2.93440096 |
94 | cellular response to superoxide (GO:0071451) | 2.93440096 |
95 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.93002851 |
96 | establishment of protein localization to mitochondrion (GO:0072655) | 2.85861212 |
97 | regulation of mitochondrial translation (GO:0070129) | 2.83352947 |
98 | regulation of autophagic vacuole assembly (GO:2000785) | 2.82974559 |
99 | dopamine transport (GO:0015872) | 2.80657222 |
100 | proteasome assembly (GO:0043248) | 2.80576108 |
101 | intracellular protein transmembrane import (GO:0044743) | 2.79676905 |
102 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.77429876 |
103 | glutathione biosynthetic process (GO:0006750) | 2.76463255 |
104 | regulation of cellular respiration (GO:0043457) | 2.74516243 |
105 | generation of precursor metabolites and energy (GO:0006091) | 2.67719337 |
106 | protein localization to mitochondrion (GO:0070585) | 2.66438788 |
107 | sequestering of actin monomers (GO:0042989) | 2.65500120 |
108 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.65164083 |
109 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.64779466 |
110 | L-phenylalanine catabolic process (GO:0006559) | 2.64779466 |
111 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.63856082 |
112 | cellular ketone body metabolic process (GO:0046950) | 2.62784925 |
113 | cholesterol biosynthetic process (GO:0006695) | 2.62475949 |
114 | viral transcription (GO:0019083) | 2.57303756 |
115 | dopamine biosynthetic process (GO:0042416) | 2.56362252 |
116 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.56236955 |
117 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.56236955 |
118 | tricarboxylic acid cycle (GO:0006099) | 2.54573742 |
119 | purine ribonucleoside biosynthetic process (GO:0046129) | 2.54294502 |
120 | purine nucleoside biosynthetic process (GO:0042451) | 2.54294502 |
121 | cotranslational protein targeting to membrane (GO:0006613) | 2.54054840 |
122 | protein targeting to ER (GO:0045047) | 2.53132328 |
123 | L-phenylalanine metabolic process (GO:0006558) | 2.52557222 |
124 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.52557222 |
125 | NADH metabolic process (GO:0006734) | 2.51898633 |
126 | GPI anchor biosynthetic process (GO:0006506) | 2.50156663 |
127 | negative regulation of protein localization to cell surface (GO:2000009) | 2.48866245 |
128 | protein localization to endoplasmic reticulum (GO:0070972) | 2.48773102 |
129 | cellular response to leptin stimulus (GO:0044320) | 2.47873999 |
130 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.46038374 |
131 | regulation of vacuole organization (GO:0044088) | 2.45290286 |
132 | ubiquinone biosynthetic process (GO:0006744) | 2.44411121 |
133 | quinone biosynthetic process (GO:1901663) | 2.44411121 |
134 | glutathione metabolic process (GO:0006749) | 2.43069637 |
135 | regulation of dopamine metabolic process (GO:0042053) | 2.42987334 |
136 | regulation of catecholamine metabolic process (GO:0042069) | 2.42987334 |
137 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.42346919 |
138 | translational termination (GO:0006415) | 2.41877041 |
139 | mannosylation (GO:0097502) | 2.41019178 |
140 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.40983536 |
141 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.39913391 |
142 | amyloid precursor protein metabolic process (GO:0042982) | 2.39717234 |
143 | cellular response to cadmium ion (GO:0071276) | 2.39397073 |
144 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.36887001 |
145 | glutathione derivative metabolic process (GO:1901685) | 2.36871818 |
146 | glutathione derivative biosynthetic process (GO:1901687) | 2.36871818 |
147 | termination of RNA polymerase III transcription (GO:0006386) | 2.36379656 |
148 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.36379656 |
149 | sterol biosynthetic process (GO:0016126) | 2.35142104 |
150 | L-methionine salvage (GO:0071267) | 2.34729260 |
151 | L-methionine biosynthetic process (GO:0071265) | 2.34729260 |
152 | amino acid salvage (GO:0043102) | 2.34729260 |
153 | ubiquinone metabolic process (GO:0006743) | 2.34439445 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.04251310 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.12584124 |
3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.86057967 |
4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.78841911 |
5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.69827233 |
6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.64406223 |
7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.62030611 |
8 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.52352977 |
9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.49250826 |
10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.48652673 |
11 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.47541333 |
12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.33112116 |
13 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.32699974 |
14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31840546 |
15 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.31627647 |
16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.15115996 |
17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.14351371 |
18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14070498 |
19 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.05338509 |
20 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.05249116 |
21 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.04779566 |
22 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.04464199 |
23 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.04313754 |
24 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99935538 |
25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.98181719 |
26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.90394965 |
27 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.87859528 |
28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84544680 |
29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.81459057 |
30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.81055851 |
31 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.80394287 |
32 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.78041474 |
33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.76688369 |
34 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.75273834 |
35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.73789938 |
36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.73105982 |
37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.67704461 |
38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.66998179 |
39 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65366360 |
40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.64662008 |
41 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.64396264 |
42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63636393 |
43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62838852 |
44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.62205197 |
45 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.60156129 |
46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.59936296 |
47 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.55877323 |
48 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.50972539 |
49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.48643253 |
50 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.44061642 |
51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42944056 |
52 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.42144704 |
53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.41725066 |
54 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.40263282 |
55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.39396930 |
56 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38384730 |
57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.36768991 |
58 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36737385 |
59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36008495 |
60 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.35512387 |
61 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34119238 |
62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34114508 |
63 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.33707423 |
64 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.33125804 |
65 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.30251012 |
66 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.29616991 |
67 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.29616991 |
68 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.28261531 |
69 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24313130 |
70 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.23746732 |
71 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23343033 |
72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22296175 |
73 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21449767 |
74 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21430810 |
75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20386996 |
76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17506682 |
77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16785845 |
78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16633814 |
79 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.16457951 |
80 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.16243321 |
81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15408316 |
82 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13210249 |
83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.13162340 |
84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13151075 |
85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12888108 |
86 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12696926 |
87 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12271005 |
88 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.12177624 |
89 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12098930 |
90 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12088005 |
91 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.11566397 |
92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11436498 |
93 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.10795256 |
94 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.10743691 |
95 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.09898669 |
96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08925854 |
97 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08799877 |
98 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08745761 |
99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08555755 |
100 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.07807500 |
101 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.07777328 |
102 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06332940 |
103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05852585 |
104 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05456551 |
105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.04729946 |
106 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04413527 |
107 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.04356128 |
108 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02375074 |
109 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.02246981 |
110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.01685270 |
111 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01414754 |
112 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01157460 |
113 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99404355 |
114 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98555812 |
115 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.97833192 |
116 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97377287 |
117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97274206 |
118 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.96842636 |
119 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.96711871 |
120 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.96638794 |
121 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96490199 |
122 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.95569344 |
123 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95542553 |
124 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.94838648 |
125 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94388122 |
126 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.93819051 |
127 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93774725 |
128 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93574231 |
129 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93510254 |
130 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93052073 |
131 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.91764624 |
132 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91591392 |
133 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.91467549 |
134 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91080609 |
135 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90998953 |
136 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.90547283 |
137 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90284814 |
138 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89626930 |
139 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.89231267 |
140 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.88551204 |
141 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88170442 |
142 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86792912 |
143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86314127 |
144 | NCOR_22424771_ChIP-Seq_293T_Human | 0.83495309 |
145 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83350240 |
146 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.83061596 |
147 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.82459550 |
148 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.82455916 |
149 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82372623 |
150 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.81564122 |
151 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80878168 |
152 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.80753172 |
153 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80351824 |
154 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.80048168 |
155 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.79917354 |
156 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79415960 |
157 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.79005664 |
158 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77993414 |
159 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.77553528 |
160 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76762606 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 3.88859352 |
2 | MP0001529_abnormal_vocalization | 3.20598895 |
3 | MP0002837_dystrophic_cardiac_calcinosis | 3.03505865 |
4 | MP0001905_abnormal_dopamine_level | 2.81275392 |
5 | MP0005671_abnormal_response_to | 2.74896920 |
6 | MP0009379_abnormal_foot_pigmentation | 2.58314820 |
7 | MP0003806_abnormal_nucleotide_metabolis | 2.48922432 |
8 | MP0009333_abnormal_splenocyte_physiolog | 2.42116817 |
9 | MP0002163_abnormal_gland_morphology | 2.39344224 |
10 | MP0006276_abnormal_autonomic_nervous | 2.19494649 |
11 | MP0006036_abnormal_mitochondrial_physio | 2.17011708 |
12 | MP0004142_abnormal_muscle_tone | 2.12755257 |
13 | MP0002822_catalepsy | 2.10677946 |
14 | MP0009785_altered_susceptibility_to | 2.10113095 |
15 | MP0003186_abnormal_redox_activity | 2.03865360 |
16 | MP0002148_abnormal_hypersensitivity_rea | 2.01040604 |
17 | MP0001835_abnormal_antigen_presentation | 1.99672562 |
18 | MP0005360_urolithiasis | 1.96567348 |
19 | MP0003329_amyloid_beta_deposits | 1.94273086 |
20 | MP0000920_abnormal_myelination | 1.93634153 |
21 | MP0002736_abnormal_nociception_after | 1.89259064 |
22 | MP0002277_abnormal_respiratory_mucosa | 1.84985910 |
23 | MP0002272_abnormal_nervous_system | 1.84806614 |
24 | MP0004043_abnormal_pH_regulation | 1.84480093 |
25 | MP0003646_muscle_fatigue | 1.83573642 |
26 | MP0006082_CNS_inflammation | 1.81073384 |
27 | MP0000749_muscle_degeneration | 1.80056657 |
28 | MP0003195_calcinosis | 1.77754049 |
29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77664395 |
30 | MP0003123_paternal_imprinting | 1.76841950 |
31 | MP0004270_analgesia | 1.74487803 |
32 | MP0001968_abnormal_touch/_nociception | 1.71784869 |
33 | MP0002064_seizures | 1.69567788 |
34 | MP0005075_abnormal_melanosome_morpholog | 1.68477542 |
35 | MP0009745_abnormal_behavioral_response | 1.67745539 |
36 | MP0005084_abnormal_gallbladder_morpholo | 1.67505953 |
37 | MP0002139_abnormal_hepatobiliary_system | 1.62192360 |
38 | MP0004036_abnormal_muscle_relaxation | 1.56126592 |
39 | MP0000751_myopathy | 1.54756588 |
40 | MP0005670_abnormal_white_adipose | 1.53465656 |
41 | MP0004885_abnormal_endolymph | 1.52253688 |
42 | MP0001984_abnormal_olfaction | 1.52234387 |
43 | MP0005025_abnormal_response_to | 1.50981508 |
44 | MP0005636_abnormal_mineral_homeostasis | 1.50922034 |
45 | MP0002735_abnormal_chemical_nociception | 1.48982774 |
46 | MP0009840_abnormal_foam_cell | 1.48682976 |
47 | MP0002733_abnormal_thermal_nociception | 1.48591829 |
48 | MP0005423_abnormal_somatic_nervous | 1.47767346 |
49 | MP0001970_abnormal_pain_threshold | 1.47588649 |
50 | MP0005332_abnormal_amino_acid | 1.47219530 |
51 | MP0005000_abnormal_immune_tolerance | 1.44753011 |
52 | MP0006035_abnormal_mitochondrial_morpho | 1.40130601 |
53 | MP0001873_stomach_inflammation | 1.39560002 |
54 | MP0001440_abnormal_grooming_behavior | 1.39345645 |
55 | MP0005085_abnormal_gallbladder_physiolo | 1.39083970 |
56 | MP0002734_abnormal_mechanical_nocicepti | 1.38872544 |
57 | MP0001800_abnormal_humoral_immune | 1.37302283 |
58 | MP0003011_delayed_dark_adaptation | 1.37229551 |
59 | MP0003786_premature_aging | 1.36987427 |
60 | MP0008058_abnormal_DNA_repair | 1.36834084 |
61 | MP0001486_abnormal_startle_reflex | 1.33923905 |
62 | MP0005058_abnormal_lysosome_morphology | 1.32684949 |
63 | MP0002638_abnormal_pupillary_reflex | 1.31352346 |
64 | MP0002572_abnormal_emotion/affect_behav | 1.30913768 |
65 | MP0001790_abnormal_immune_system | 1.30475501 |
66 | MP0005387_immune_system_phenotype | 1.30475501 |
67 | MP0003635_abnormal_synaptic_transmissio | 1.28499534 |
68 | MP0002723_abnormal_immune_serum | 1.28223128 |
69 | MP0005451_abnormal_body_composition | 1.25945293 |
70 | MP0004742_abnormal_vestibular_system | 1.25835046 |
71 | MP0009046_muscle_twitch | 1.25707692 |
72 | MP0002420_abnormal_adaptive_immunity | 1.23511312 |
73 | MP0000343_altered_response_to | 1.22647869 |
74 | MP0001853_heart_inflammation | 1.22453432 |
75 | MP0001819_abnormal_immune_cell | 1.22430178 |
76 | MP0004145_abnormal_muscle_electrophysio | 1.20182458 |
77 | MP0008995_early_reproductive_senescence | 1.19663908 |
78 | MP0002452_abnormal_antigen_presenting | 1.19653149 |
79 | MP0008469_abnormal_protein_level | 1.18917608 |
80 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17687556 |
81 | MP0004924_abnormal_behavior | 1.15529455 |
82 | MP0005386_behavior/neurological_phenoty | 1.15529455 |
83 | MP0001845_abnormal_inflammatory_respons | 1.14809232 |
84 | MP0003136_yellow_coat_color | 1.14411552 |
85 | MP0003693_abnormal_embryo_hatching | 1.13849263 |
86 | MP0003436_decreased_susceptibility_to | 1.13821419 |
87 | MP0008872_abnormal_physiological_respon | 1.13518554 |
88 | MP0003137_abnormal_impulse_conducting | 1.13354809 |
89 | MP0001485_abnormal_pinna_reflex | 1.13340243 |
90 | MP0005379_endocrine/exocrine_gland_phen | 1.12332451 |
91 | MP0004147_increased_porphyrin_level | 1.12065516 |
92 | MP0002229_neurodegeneration | 1.11110752 |
93 | MP0001501_abnormal_sleep_pattern | 1.10770945 |
94 | MP0005319_abnormal_enzyme/_coenzyme | 1.10462728 |
95 | MP0002132_abnormal_respiratory_system | 1.10440260 |
96 | MP0005551_abnormal_eye_electrophysiolog | 1.10040525 |
97 | MP0000685_abnormal_immune_system | 1.09649064 |
98 | MP0004957_abnormal_blastocyst_morpholog | 1.09347270 |
99 | MP0006072_abnormal_retinal_apoptosis | 1.09288972 |
100 | MP0005408_hypopigmentation | 1.06906602 |
101 | MP0005645_abnormal_hypothalamus_physiol | 1.06632270 |
102 | MP0002419_abnormal_innate_immunity | 1.06328541 |
103 | MP0005365_abnormal_bile_salt | 1.05193216 |
104 | MP0005646_abnormal_pituitary_gland | 1.05180109 |
105 | MP0004215_abnormal_myocardial_fiber | 1.04627821 |
106 | MP0002067_abnormal_sensory_capabilities | 1.03476653 |
107 | MP0001502_abnormal_circadian_rhythm | 1.03468948 |
108 | MP0005171_absent_coat_pigmentation | 1.02509410 |
109 | MP0010386_abnormal_urinary_bladder | 1.02154097 |
110 | MP0002063_abnormal_learning/memory/cond | 1.00361048 |
111 | MP0004019_abnormal_vitamin_homeostasis | 1.00281726 |
112 | MP0005330_cardiomyopathy | 1.00107070 |
113 | MP0005535_abnormal_body_temperature | 0.99219851 |
114 | MP0001963_abnormal_hearing_physiology | 0.99098726 |
115 | MP0002876_abnormal_thyroid_physiology | 0.99088186 |
116 | MP0005409_darkened_coat_color | 0.99014657 |
117 | MP0010155_abnormal_intestine_physiology | 0.98969646 |
118 | MP0009764_decreased_sensitivity_to | 0.98056288 |
119 | MP0001666_abnormal_nutrient_absorption | 0.98043242 |
120 | MP0002095_abnormal_skin_pigmentation | 0.96312055 |
121 | MP0002160_abnormal_reproductive_system | 0.94207548 |
122 | MP0003690_abnormal_glial_cell | 0.93161069 |
123 | MP0005389_reproductive_system_phenotype | 0.92559265 |
124 | MP0000716_abnormal_immune_system | 0.92474020 |
125 | MP0000230_abnormal_systemic_arterial | 0.92127545 |
126 | MP0001764_abnormal_homeostasis | 0.92072280 |
127 | MP0004381_abnormal_hair_follicle | 0.91494840 |
128 | MP0009643_abnormal_urine_homeostasis | 0.90664719 |
129 | MP0001727_abnormal_embryo_implantation | 0.90350671 |
130 | MP0003075_altered_response_to | 0.90239994 |
131 | MP0000372_irregular_coat_pigmentation | 0.89832219 |
132 | MP0001986_abnormal_taste_sensitivity | 0.89238889 |
133 | MP0001919_abnormal_reproductive_system | 0.88437923 |
134 | MP0005083_abnormal_biliary_tract | 0.88325447 |
135 | MP0001664_abnormal_digestion | 0.88023178 |
136 | MP0000750_abnormal_muscle_regeneration | 0.87125464 |
137 | MP0001765_abnormal_ion_homeostasis | 0.86856911 |
138 | MP0002066_abnormal_motor_capabilities/c | 0.85836452 |
139 | MP0002234_abnormal_pharynx_morphology | 0.85424699 |
140 | MP0005165_increased_susceptibility_to | 0.85264086 |
141 | MP0002972_abnormal_cardiac_muscle | 0.84611292 |
142 | MP0005620_abnormal_muscle_contractility | 0.84482778 |
143 | MP0005464_abnormal_platelet_physiology | 0.84333281 |
144 | MP0008789_abnormal_olfactory_epithelium | 0.83580142 |
145 | MP0000490_abnormal_crypts_of | 0.82577318 |
146 | MP0002332_abnormal_exercise_endurance | 0.82239773 |
147 | MP0003634_abnormal_glial_cell | 0.82234867 |
148 | MP0005166_decreased_susceptibility_to | 0.81908915 |
149 | MP0006292_abnormal_olfactory_placode | 0.81662149 |
150 | MP0000604_amyloidosis | 0.81297785 |
151 | MP0002429_abnormal_blood_cell | 0.79512120 |
152 | MP0005410_abnormal_fertilization | 0.79446769 |
153 | MP0003718_maternal_effect | 0.78847523 |
154 | MP0002398_abnormal_bone_marrow | 0.77978110 |
155 | MP0000026_abnormal_inner_ear | 0.77143203 |
156 | MP0000689_abnormal_spleen_morphology | 0.76919779 |
157 | MP0000566_synostosis | 0.76746730 |
158 | MP0001663_abnormal_digestive_system | 0.75790184 |
159 | MP0002653_abnormal_ependyma_morphology | 0.75122618 |
160 | MP0003866_abnormal_defecation | 0.73269429 |
161 | MP0003763_abnormal_thymus_physiology | 0.72257121 |
162 | MP0002722_abnormal_immune_system | 0.70974425 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 6.51648976 |
2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.98450666 |
3 | Mitochondrial inheritance (HP:0001427) | 5.92811234 |
4 | Acute encephalopathy (HP:0006846) | 5.75393889 |
5 | Progressive macrocephaly (HP:0004481) | 5.29525030 |
6 | Hepatocellular necrosis (HP:0001404) | 5.27792373 |
7 | Increased CSF lactate (HP:0002490) | 5.08320675 |
8 | Hepatic necrosis (HP:0002605) | 4.83328552 |
9 | Increased hepatocellular lipid droplets (HP:0006565) | 4.66656140 |
10 | Lipid accumulation in hepatocytes (HP:0006561) | 4.45705164 |
11 | Renal Fanconi syndrome (HP:0001994) | 4.32697004 |
12 | Cerebral edema (HP:0002181) | 4.16216894 |
13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.09473438 |
14 | Increased intramyocellular lipid droplets (HP:0012240) | 4.06604882 |
15 | Abnormality of glycolysis (HP:0004366) | 3.95316120 |
16 | Increased serum pyruvate (HP:0003542) | 3.95316120 |
17 | Respiratory failure (HP:0002878) | 3.77868479 |
18 | Increased muscle lipid content (HP:0009058) | 3.73687231 |
19 | Lactic acidosis (HP:0003128) | 3.61860135 |
20 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.61737470 |
21 | 3-Methylglutaconic aciduria (HP:0003535) | 3.58940325 |
22 | Leukodystrophy (HP:0002415) | 3.51556652 |
23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.50547691 |
24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.50547691 |
25 | Optic disc pallor (HP:0000543) | 3.48682331 |
26 | Exercise intolerance (HP:0003546) | 3.46807569 |
27 | Reticulocytopenia (HP:0001896) | 3.40827284 |
28 | Increased serum lactate (HP:0002151) | 3.20166878 |
29 | Neuroendocrine neoplasm (HP:0100634) | 3.16532619 |
30 | Pheochromocytoma (HP:0002666) | 3.11471556 |
31 | Exertional dyspnea (HP:0002875) | 3.07981823 |
32 | Abnormality of renal resorption (HP:0011038) | 3.04824843 |
33 | Myokymia (HP:0002411) | 3.00300933 |
34 | Abnormality of urine glucose concentration (HP:0011016) | 2.79686225 |
35 | Glycosuria (HP:0003076) | 2.79686225 |
36 | Respiratory difficulties (HP:0002880) | 2.77554696 |
37 | Hyperphosphaturia (HP:0003109) | 2.73997382 |
38 | Lethargy (HP:0001254) | 2.70545938 |
39 | Aplastic anemia (HP:0001915) | 2.64682828 |
40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.51568202 |
41 | CNS demyelination (HP:0007305) | 2.45168598 |
42 | Parakeratosis (HP:0001036) | 2.42062112 |
43 | Pallor (HP:0000980) | 2.41955968 |
44 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.38909399 |
45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36670226 |
46 | Dicarboxylic aciduria (HP:0003215) | 2.36670226 |
47 | X-linked dominant inheritance (HP:0001423) | 2.35961985 |
48 | Abnormal urine phosphate concentration (HP:0012599) | 2.32925918 |
49 | Hypothermia (HP:0002045) | 2.31831360 |
50 | Neurofibrillary tangles (HP:0002185) | 2.29786106 |
51 | Testicular atrophy (HP:0000029) | 2.29102855 |
52 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.28824939 |
53 | Emotional lability (HP:0000712) | 2.28166783 |
54 | Methylmalonic aciduria (HP:0012120) | 2.27950363 |
55 | Type I transferrin isoform profile (HP:0003642) | 2.24512286 |
56 | Cerebral hemorrhage (HP:0001342) | 2.21285308 |
57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.20618292 |
58 | Sensory axonal neuropathy (HP:0003390) | 2.15535370 |
59 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.15487081 |
60 | Abnormal pupillary function (HP:0007686) | 2.13997168 |
61 | Cholecystitis (HP:0001082) | 2.10589006 |
62 | Abnormal gallbladder physiology (HP:0012438) | 2.10589006 |
63 | Abnormality of magnesium homeostasis (HP:0004921) | 2.08224654 |
64 | Nausea (HP:0002018) | 2.07958006 |
65 | Vomiting (HP:0002013) | 2.04376113 |
66 | Renal tubular dysfunction (HP:0000124) | 2.04077925 |
67 | Microvesicular hepatic steatosis (HP:0001414) | 2.03122915 |
68 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.00916239 |
69 | Hyperventilation (HP:0002883) | 2.00804423 |
70 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.99451065 |
71 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.99451065 |
72 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.98122885 |
73 | Hypomagnesemia (HP:0002917) | 1.96760016 |
74 | Pancytopenia (HP:0001876) | 1.95622909 |
75 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.95325048 |
76 | Nemaline bodies (HP:0003798) | 1.94304706 |
77 | Palpitations (HP:0001962) | 1.94251575 |
78 | Methylmalonic acidemia (HP:0002912) | 1.94191267 |
79 | Limb dystonia (HP:0002451) | 1.91856914 |
80 | Delayed CNS myelination (HP:0002188) | 1.88998922 |
81 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.88894898 |
82 | Muscle fiber inclusion bodies (HP:0100299) | 1.86665529 |
83 | Abnormal hemoglobin (HP:0011902) | 1.85619154 |
84 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.85119827 |
85 | Exercise-induced myalgia (HP:0003738) | 1.83692858 |
86 | Cerebral palsy (HP:0100021) | 1.83622521 |
87 | Degeneration of anterior horn cells (HP:0002398) | 1.83069236 |
88 | Abnormality of the anterior horn cell (HP:0006802) | 1.83069236 |
89 | Increased circulating renin level (HP:0000848) | 1.82104723 |
90 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.81971408 |
91 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.81971408 |
92 | Abnormal protein glycosylation (HP:0012346) | 1.81971408 |
93 | Abnormal glycosylation (HP:0012345) | 1.81971408 |
94 | Generalized aminoaciduria (HP:0002909) | 1.80704906 |
95 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.78072176 |
96 | Congenital, generalized hypertrichosis (HP:0004540) | 1.76709337 |
97 | Metabolic alkalosis (HP:0200114) | 1.76396350 |
98 | Abnormality of T cell physiology (HP:0011840) | 1.76020707 |
99 | Retinal dysplasia (HP:0007973) | 1.74605878 |
100 | Hypoplasia of the uterus (HP:0000013) | 1.73496478 |
101 | Amniotic constriction ring (HP:0009775) | 1.73087037 |
102 | Abnormality of placental membranes (HP:0011409) | 1.73087037 |
103 | Muscle fiber atrophy (HP:0100295) | 1.73059207 |
104 | Chronic obstructive pulmonary disease (HP:0006510) | 1.72480702 |
105 | Obstructive lung disease (HP:0006536) | 1.72480702 |
106 | Cerebral hypomyelination (HP:0006808) | 1.72033165 |
107 | Myopathic facies (HP:0002058) | 1.71835986 |
108 | Calf muscle hypertrophy (HP:0008981) | 1.71531002 |
109 | Abnormality of secondary sexual hair (HP:0009888) | 1.71390080 |
110 | Abnormality of the axillary hair (HP:0100134) | 1.71390080 |
111 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.70666738 |
112 | Ragged-red muscle fibers (HP:0003200) | 1.70254141 |
113 | Oral leukoplakia (HP:0002745) | 1.70016056 |
114 | Type 2 muscle fiber atrophy (HP:0003554) | 1.69912444 |
115 | Myotonia (HP:0002486) | 1.67063048 |
116 | Muscle fiber splitting (HP:0003555) | 1.66982063 |
117 | Rough bone trabeculation (HP:0100670) | 1.66439877 |
118 | Sudden death (HP:0001699) | 1.65255422 |
119 | Reduced antithrombin III activity (HP:0001976) | 1.64867282 |
120 | Macrocytic anemia (HP:0001972) | 1.64843381 |
121 | Petechiae (HP:0000967) | 1.64691995 |
122 | Paralysis (HP:0003470) | 1.64554051 |
123 | Abnormality of alanine metabolism (HP:0010916) | 1.64434037 |
124 | Hyperalaninemia (HP:0003348) | 1.64434037 |
125 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.64434037 |
126 | Abnormal number of erythroid precursors (HP:0012131) | 1.64325522 |
127 | Hypoplastic left heart (HP:0004383) | 1.63902818 |
128 | Microretrognathia (HP:0000308) | 1.63165737 |
129 | Muscle stiffness (HP:0003552) | 1.62945126 |
130 | Metabolic acidosis (HP:0001942) | 1.62779902 |
131 | Blindness (HP:0000618) | 1.62222201 |
132 | Hyperglycinemia (HP:0002154) | 1.61553142 |
133 | Cleft eyelid (HP:0000625) | 1.61402013 |
134 | Delusions (HP:0000746) | 1.60838043 |
135 | Vacuolated lymphocytes (HP:0001922) | 1.60658742 |
136 | Thrombocytosis (HP:0001894) | 1.59529456 |
137 | Stomatitis (HP:0010280) | 1.59020241 |
138 | Rhabdomyolysis (HP:0003201) | 1.58599049 |
139 | Cerebral inclusion bodies (HP:0100314) | 1.55836770 |
140 | Conjunctival hamartoma (HP:0100780) | 1.52652521 |
141 | Anxiety (HP:0000739) | 1.50560334 |
142 | Alkalosis (HP:0001948) | 1.50495131 |
143 | Spastic paraparesis (HP:0002313) | 1.49972666 |
144 | Myoglobinuria (HP:0002913) | 1.48875353 |
145 | Hypokalemic alkalosis (HP:0001949) | 1.48509103 |
146 | Abnormality of glycine metabolism (HP:0010895) | 1.48424500 |
147 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.48424500 |
148 | Hyperglycinuria (HP:0003108) | 1.47926754 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VRK2 | 5.61239286 |
2 | ARAF | 3.37760540 |
3 | STK39 | 3.35536682 |
4 | NME1 | 3.03346220 |
5 | OXSR1 | 2.85341787 |
6 | MAP3K12 | 2.67688853 |
7 | CASK | 2.66037581 |
8 | WNK4 | 2.64826057 |
9 | MYLK | 2.59821069 |
10 | STK16 | 2.48503713 |
11 | ZAK | 2.31276984 |
12 | MUSK | 2.25295474 |
13 | TLK1 | 2.22148128 |
14 | TAOK3 | 2.18349412 |
15 | NME2 | 2.14831434 |
16 | BCKDK | 2.10598946 |
17 | LIMK1 | 2.06532003 |
18 | GRK7 | 2.02500207 |
19 | MST4 | 2.01659446 |
20 | CDK19 | 1.87443575 |
21 | MAPKAPK5 | 1.87261520 |
22 | GRK5 | 1.86901561 |
23 | NEK1 | 1.82234673 |
24 | PIM2 | 1.65363372 |
25 | OBSCN | 1.65057314 |
26 | TESK2 | 1.58646829 |
27 | MAP4K2 | 1.58225417 |
28 | PHKG2 | 1.53822599 |
29 | PHKG1 | 1.53822599 |
30 | TNIK | 1.45459196 |
31 | ADRBK2 | 1.43232912 |
32 | PBK | 1.42844257 |
33 | MAP3K11 | 1.39681289 |
34 | DYRK2 | 1.39254017 |
35 | LRRK2 | 1.34161098 |
36 | MAP4K1 | 1.30795855 |
37 | CAMK2B | 1.30794889 |
38 | CAMK2D | 1.23089337 |
39 | NUAK1 | 1.22380401 |
40 | TXK | 1.21492393 |
41 | BRAF | 1.20541460 |
42 | TAF1 | 1.18134157 |
43 | TNK2 | 1.16668407 |
44 | CAMK2G | 1.10948065 |
45 | WNK3 | 1.08929628 |
46 | CAMK2A | 1.08464983 |
47 | ILK | 1.05698136 |
48 | BCR | 1.05121090 |
49 | CSNK1G3 | 1.04526430 |
50 | DAPK3 | 1.04446945 |
51 | PKN1 | 1.03688035 |
52 | TBK1 | 1.02770584 |
53 | TESK1 | 1.02112153 |
54 | BMPR2 | 0.97659908 |
55 | IKBKB | 0.95471226 |
56 | MAPK15 | 0.94000810 |
57 | VRK1 | 0.93480858 |
58 | MAP2K2 | 0.93277556 |
59 | UHMK1 | 0.93064328 |
60 | ADRBK1 | 0.91040098 |
61 | PNCK | 0.86696212 |
62 | ROCK2 | 0.86337511 |
63 | MAP2K7 | 0.84703273 |
64 | AURKA | 0.84336738 |
65 | EPHB2 | 0.83163862 |
66 | EIF2AK1 | 0.81592071 |
67 | ITK | 0.78945025 |
68 | KDR | 0.77569748 |
69 | ABL2 | 0.76780332 |
70 | MAPK13 | 0.75906787 |
71 | GRK6 | 0.74307494 |
72 | BMPR1B | 0.73907669 |
73 | PDK2 | 0.73228045 |
74 | TAOK2 | 0.73040665 |
75 | MAPKAPK3 | 0.72554829 |
76 | EPHA4 | 0.72059334 |
77 | PIK3CA | 0.71787348 |
78 | BUB1 | 0.69512607 |
79 | IRAK3 | 0.68847012 |
80 | LMTK2 | 0.68201905 |
81 | PTK2B | 0.67575509 |
82 | PRKCE | 0.65697801 |
83 | RPS6KA5 | 0.65255573 |
84 | DYRK3 | 0.63842473 |
85 | SRPK1 | 0.62569319 |
86 | TYK2 | 0.62494032 |
87 | PINK1 | 0.62239508 |
88 | NTRK1 | 0.61078663 |
89 | CSNK2A2 | 0.60682409 |
90 | SMG1 | 0.60617666 |
91 | PAK1 | 0.60278255 |
92 | BRSK1 | 0.60078902 |
93 | CSNK2A1 | 0.59486746 |
94 | PRKACA | 0.58718948 |
95 | BTK | 0.57715087 |
96 | PAK4 | 0.57365496 |
97 | FGR | 0.56957884 |
98 | CSNK1G2 | 0.56948401 |
99 | PLK2 | 0.56917130 |
100 | CDK14 | 0.56655079 |
101 | MARK1 | 0.56499446 |
102 | SIK3 | 0.56204581 |
103 | AURKB | 0.56001537 |
104 | FES | 0.55772387 |
105 | MOS | 0.54546594 |
106 | ZAP70 | 0.54270921 |
107 | CSNK1G1 | 0.53845268 |
108 | DAPK1 | 0.53267984 |
109 | CDK18 | 0.52914722 |
110 | CCNB1 | 0.52714588 |
111 | SGK223 | 0.51897104 |
112 | SGK494 | 0.51897104 |
113 | CDK15 | 0.51437791 |
114 | EIF2AK3 | 0.51386929 |
115 | CDK8 | 0.51038967 |
116 | PLK4 | 0.50975874 |
117 | LYN | 0.50866171 |
118 | MARK3 | 0.49407954 |
119 | PLK1 | 0.49372493 |
120 | PRKCG | 0.49149278 |
121 | TEC | 0.48933789 |
122 | CDK11A | 0.48818424 |
123 | CHEK2 | 0.48301057 |
124 | MAPK4 | 0.47929076 |
125 | TIE1 | 0.47737162 |
126 | CDK5 | 0.46810468 |
127 | SYK | 0.45557167 |
128 | INSRR | 0.45117794 |
129 | MAPK12 | 0.44652426 |
130 | CDC7 | 0.44345681 |
131 | DAPK2 | 0.43630534 |
132 | PASK | 0.43060766 |
133 | KSR2 | 0.42788993 |
134 | CAMK1 | 0.42737186 |
135 | PDK4 | 0.40747915 |
136 | PDK3 | 0.40747915 |
137 | PRKCQ | 0.40562406 |
138 | PLK3 | 0.40274844 |
139 | RAF1 | 0.39627814 |
140 | CSNK1A1L | 0.39358521 |
141 | NEK6 | 0.38732400 |
142 | PRPF4B | 0.37844147 |
143 | PRKG2 | 0.37346209 |
144 | PAK3 | 0.36449423 |
145 | PIM1 | 0.36180519 |
146 | TRIM28 | 0.35674942 |
147 | PIK3CG | 0.34598979 |
148 | GRK1 | 0.34459873 |
149 | MAP2K6 | 0.34233655 |
150 | CSF1R | 0.32417396 |
151 | CAMKK2 | 0.31740890 |
152 | PRKCD | 0.29551332 |
153 | RPS6KB2 | 0.29396607 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.09238084 |
2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.08500504 |
3 | Alzheimers disease_Homo sapiens_hsa05010 | 3.88476826 |
4 | Huntingtons disease_Homo sapiens_hsa05016 | 3.37685271 |
5 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.26408735 |
6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.76180558 |
7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.63796265 |
8 | Ribosome_Homo sapiens_hsa03010 | 2.58925172 |
9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.53208897 |
10 | Proteasome_Homo sapiens_hsa03050 | 2.34430327 |
11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.13360958 |
12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.11873433 |
13 | Protein export_Homo sapiens_hsa03060 | 2.04263615 |
14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.03455423 |
15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.84371160 |
16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.64847885 |
17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62556535 |
18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.56785665 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51463282 |
20 | DNA replication_Homo sapiens_hsa03030 | 1.50065653 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48925024 |
22 | Mismatch repair_Homo sapiens_hsa03430 | 1.44532359 |
23 | Homologous recombination_Homo sapiens_hsa03440 | 1.44459504 |
24 | Asthma_Homo sapiens_hsa05310 | 1.43141217 |
25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37111193 |
26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36677959 |
27 | RNA polymerase_Homo sapiens_hsa03020 | 1.36149337 |
28 | Base excision repair_Homo sapiens_hsa03410 | 1.35363613 |
29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34799681 |
30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30668211 |
31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30494953 |
32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28294289 |
33 | Allograft rejection_Homo sapiens_hsa05330 | 1.25981159 |
34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24733694 |
35 | Peroxisome_Homo sapiens_hsa04146 | 1.21757738 |
36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21102926 |
37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19500318 |
38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19077340 |
39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.15417084 |
40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12342928 |
41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11641377 |
42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08761167 |
43 | Spliceosome_Homo sapiens_hsa03040 | 1.05036175 |
44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.04772627 |
45 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03301586 |
46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02648855 |
47 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.01506488 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01191897 |
49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99949237 |
50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99705814 |
51 | Metabolic pathways_Homo sapiens_hsa01100 | 0.97593702 |
52 | Basal transcription factors_Homo sapiens_hsa03022 | 0.96358537 |
53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95430027 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95148558 |
55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94191547 |
56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91334986 |
57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90818401 |
58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87298982 |
59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86689356 |
60 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.86589161 |
61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84127976 |
62 | RNA degradation_Homo sapiens_hsa03018 | 0.83615597 |
63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78543131 |
64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73721182 |
65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73526135 |
66 | Nicotine addiction_Homo sapiens_hsa05033 | 0.72674933 |
67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72392651 |
68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71538328 |
69 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68994144 |
70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68584357 |
71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67581586 |
72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66785923 |
73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63158659 |
74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61535638 |
75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61339042 |
76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60306277 |
77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.60051005 |
78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59755403 |
79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59473254 |
80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58573587 |
81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57669977 |
82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55911337 |
83 | RNA transport_Homo sapiens_hsa03013 | 0.53895595 |
84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50868398 |
85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.50309696 |
86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50034978 |
87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49123949 |
88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48453900 |
89 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48118944 |
90 | Phototransduction_Homo sapiens_hsa04744 | 0.47862081 |
91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47649613 |
92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47446721 |
93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47366894 |
94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45398476 |
95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43464733 |
96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42533575 |
97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42518960 |
98 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42201956 |
99 | Mineral absorption_Homo sapiens_hsa04978 | 0.42189626 |
100 | Purine metabolism_Homo sapiens_hsa00230 | 0.41512201 |
101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38046854 |
102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37387156 |
103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35789634 |
104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35280344 |
105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35180875 |
106 | Phagosome_Homo sapiens_hsa04145 | 0.34866379 |
107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33389069 |
108 | Taste transduction_Homo sapiens_hsa04742 | 0.33008931 |
109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32738397 |
110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31849240 |
111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31222922 |
112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.30988939 |
113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30726765 |
114 | Morphine addiction_Homo sapiens_hsa05032 | 0.30699334 |
115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29105661 |
116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28861953 |
117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27059346 |
118 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26143913 |
119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26110961 |
120 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.24202575 |
121 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.23933383 |
122 | Circadian entrainment_Homo sapiens_hsa04713 | 0.22006501 |
123 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.19424031 |
124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19013417 |
125 | Cocaine addiction_Homo sapiens_hsa05030 | 0.18224748 |
126 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.17600854 |
127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16211624 |
128 | Bile secretion_Homo sapiens_hsa04976 | 0.15866645 |
129 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15604390 |
130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14881650 |
131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14211344 |